Odds ratio (95% Confidence interval) | ||||||
---|---|---|---|---|---|---|
Physical | Financial | Education/information | Personal Control | System of Care | Resources | |
Sex | ||||||
Male (reference) | ||||||
Female | 2.50 (1.54–4.07)* | 0.52 (0.22–1.21) | 0.79 (0.54–1.15) | 1.95 (0.59–6.42) | 1.19 (0.47–3.05) | 0.62 (0.43–0.91)* |
Age group (in years) | ||||||
< 40, 40–59, 60–69, ≥ 70 | 1.25 (1.00–1.57) | 1.03 (0.70–1.51) | 0.94 (0.78–1.13) | 0.80 (0.46–1.39) | 0.77 (0.49–1.22) | 0.98 (0.81–1.18) |
Cancer type | ||||||
Breast (reference) | ||||||
Colon | 1.05 (0.52–2.10) | 0.52 (0.15–1.81) | 1.11 (0.59–2.08) | 0.59 (0.07–5.12) | 1.99 (0.44–9.08) | 1.34 (0.70–2.60) |
Lung | 0.72 (0.31–1.69) | 0.15 (0.02–1.31) | 1.72 (0.87–3.43) | 0.78 (0.09–7.02) | 0.85 (0.09–7.93) | 1.39 (0.67–2.87) |
Stomach | 0.96 (0.44–2.10) | 0.27 (0.05–1.40) | 1.27 (0.63–2.58) | 1.94 (0.34–11.00) | 1.56 (0.26–9.24) | 1.49 (0.73–3.03) |
Other | 0.78 (0.45–1.33) | 0.53 (0.20–1.35) | 1.11 (0.69–1.81) | 1.17 (0.35–3.95) | 1.56 (0.47–5.20) | 1.23 (0.74–2.04) |
Multi primary | 2.33 (0.85–6.43) | 0.35 (0.04–2.94) | 0.49 (0.16–1.53) | 3.97 (0.67–23.40) | 1.95 (0.21–18.40) | 1.25 (0.47–3.31) |
Never diagnosed with cancer | 0.41 (0.17–0.97)* | 0.25 (0.06–0.98)* | 1.77 (1.00–3.13) | 0.00 (0.00-Inf) | 1.83 (0.47–7.20) | 1.40 (0.77–2.54) |
Treatment course | ||||||
Pretreatment (reference) | ||||||
Ongoing | 5.08 (2.64–9.78)* | 0.71 (0.32–1.59) | 1.28 (0.85–1.93) | 1.31 (0.43–3.96) | 0.70 (0.25–1.98) | 0.51 (0.34–0.78)* |
Completed | 5.35 (2.74–10.40)* | 0.91 (0.41–2.06) | 0.78 (0.52–1.18) | 0.28 (0.05–1.47) | 0.69 (0.26–1.80) | 0.68 (0.46–1.01) |
Residence | ||||||
CDOa (reference) | ||||||
Within KPb | 1.12 (0.74–1.70) | 0.85 (0.42–1.73) | 0.75 (0.53–1.07) | 1.19 (0.44–3.22) | 1.44 (0.64–3.25) | 1.16 (0.82–1.65) |
Outside KPb | 0.22 (0.06–0.79)* | 0.80 (0.18–3.58) | 0.90 (0.45–1.78) | 1.67 (0.34–8.25) | 0.64 (0.08–5.12) | 1.51 (0.78–2.95) |
Symptom | ||||||
Yes (reference) | ||||||
No | 8.69 (5.35–14.10)* | 0.67 (0.35–1.29) | 0.46 (0.33–0.64)* | 0.99 (0.38–2.59) | 0.79 (0.35–1.76) | 0.69 (0.50–0.96)* |
Past consultation history at KCCc | ||||||
Yes (reference) | ||||||
No | 1.22 (0.65–2.28) | 1.91 (0.75–4.81) | 1.18 (0.68–2.06) | 0.53 (0.07–4.16) | 0.91 (0.21–4.00) | 0.54 (0.27–1.07) |
Emotions/Mental Health | Social Support | Communications | Provider Relationship | Cure | Employment | |
Sex | ||||||
Male (reference) | ||||||
Female | 1.60 (1.05–2.43)* | 1.76 (0.38–8.23) | 1.81 (0.80–4.08) | 1.25 (0.72–2.17) | 0.77 (0.51–1.15) | 0.34 (0.10–1.21) |
Age group (in years) | ||||||
< 40, 40–59, 60–69, ≥ 70 | 0.95 (0.78–1.16) | 1.30 (0.69–2.47) | 1.18 (0.82–1.70) | 0.98 (0.75–1.29) | 1.03 (0.84–1.25) | 0.37 (0.20–0.67)* |
Cancer type | ||||||
Breast (reference) | ||||||
Colon | 0.83 (0.43–1.62) | 0.00 (0.00-Inf) | 1.28 (0.48–3.41) | 1.96 (0.86–4.48) | 1.03 (0.52–2.04) | 0.00 (0.00-Inf) |
Lung | 0.73 (0.33–1.61) | 0.00 (0.00-Inf) | 0.46 (0.10–2.17) | 1.88 (0.73–4.83) | 1.46 (0.71–3.02) | 0.27 (0.02–2.86) |
Stomach | 0.93 (0.45–1.93) | 0.41 (0.04–4.15) | 0.46 (0.10–2.20) | 1.17 (0.41–3.31) | 1.13 (0.53–2.42) | 0.17 (0.02–1.86) |
Other | 0.91 (0.56–1.47) | 0.43 (0.10–1.88) | 0.63 (0.26–1.49) | 1.16 (0.57–2.36) | 1.14 (0.68–1.92) | 0.61 (0.19–1.98) |
Multi primary | 0.89 (0.33–2.40) | 2.03 (0.32–13.00) | 2.00 (0.57–7.00) | 1.84 (0.55–6.18) | 0.98 (0.35–2.73) | 0.00 (0.00-Inf) |
Never diagnosed with cancer | 1.52 (0.85–2.71) | 0.27 (0.03–2.58) | 0.31 (0.07–1.45) | 1.43 (0.59–3.44) | 1.01 (0.53–1.93) | 0.00 (0.00-Inf) |
Treatment course | ||||||
Pretreatment (reference) | ||||||
Ongoing | 1.14 (0.72–1.79) | 1.36 (0.32–5.78) | 1.48 (0.66–3.31) | 1.63 (0.86–3.09) | 0.97 (0.63–1.48) | 1.01 (0.29–3.55) |
Completed | 1.23 (0.79–1.91) | 1.42 (0.31–6.46) | 0.68 (0.26–1.73) | 1.26 (0.66–2.42) | 0.53 (0.34–0.82)* | 2.72 (0.86–8.57) |
Residence | ||||||
CDOa (reference) | ||||||
Within KPb | 1.18 (0.82–1.70) | 0.30 (0.07–1.38) | 1.20 (0.63–2.30) | 1.18 (0.71–1.94) | 1.20 (0.83–1.74) | 1.03 (0.41–2.58) |
Outside KPb | 0.79 (0.35–1.79) | 1.01 (0.12–8.62) | 0.39 (0.05–3.02) | 0.85 (0.29–2.54) | 1.92 (0.98–3.75) | 0.00 (0.00-Inf) |
Symptom | ||||||
Yes (reference) | ||||||
No | 1.78 (1.25–2.53)* | 1.21 (0.41–3.61) | 1.31 (0.70–2.46) | 1.49 (0.92–2.42) | 0.56 (0.40–0.79)* | 1.59 (0.62–4.10) |
Past consultation history at KCCc | ||||||
Yes (reference) | ||||||
No | 0.85 (0.47–1.55) | 0.00 (0.00-Inf) | 1.13 (0.42–3.03) | 0.62 (0.24–1.60) | 0.31 (0.13–0.74)* | 0.44 (0.05–3.48) |